Log in
Enquire now
‌

US Patent 9605319 Gene signatures for cancer diagnosis and prognosis

Patent 9605319 was granted and assigned to Myriad Genetics on March, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent
0

Patent attributes

Current Assignee
Myriad Genetics
Myriad Genetics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
96053190
Patent Inventor Names
Julia Reid0
Susanne Wagner0
Alexander Gutin0
Steven Stone0
Date of Patent
March 28, 2017
0
Patent Application Number
138199630
Date Filed
August 30, 2011
0
Patent Citations Received
‌
US Patent 12026683 System and method for risk assessment of a third party application for controlling competitive migration
0
Patent Primary Examiner
‌
Joseph G. Dauner
0
Patent abstract

Biomarkers and methods using the biomarkers for molecular detection and classification of disease and, particularly, molecular markers for cancer diagnosis and prognosis and methods of use thereof are provided.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9605319 Gene signatures for cancer diagnosis and prognosis

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.